LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

Search

Mersana Therapeutics Inc

Closed

SectorHealthcare

7.02 2.93

Overview

Share price change

24h

Current

Min

6.59

Max

7.08

Key metrics

By Trading Economics

Income

-173K

-24M

Sales

302K

3.1M

Profit margin

-795.026

Employees

102

EBITDA

-303K

-23M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+419.06% upside

Dividends

By Dow Jones

Next Earnings

12 lis 2025

Market Stats

By TradingEconomics

Market Cap

6.8M

37M

Previous open

4.09

Previous close

7.02

News Sentiment

By Acuity

40%

60%

147 / 371 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Mersana Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

10 sty 2025, 12:00 UTC

Major Market Movers

Mersana Shares Rise on Advances With Breast-Cancer Treatment

Peer Comparison

Price change

Mersana Therapeutics Inc Forecast

Price Target

By TipRanks

419.06% upside

12 Months Forecast

Average 35.4 USD  419.06%

High 50 USD

Low 17 USD

Based on 7 Wall Street analysts offering 12 month price targets forMersana Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

7 ratings

7

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

0.311 / 0.355Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

No Evidence

Sentiment

By Acuity

147 / 371 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat